FDA Import Refusal AEK-9438325-2/10003/1 — AVVISTO THERAPEUTICS LLC
The FDA refused shipment AEK-9438325-2/10003/1 from AVVISTO THERAPEUTICS LLC (India) on Feb 20, 2026. The refused product falls under Drugs and Biologics — BROMOCRIPTINE MESYLATE (ENZYME INHIBITOR). Cited charges: 118,3280
Refusal Details
- Date
- Feb 20, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 64FDA24 BROMOCRIPTINE MESYLATE (ENZYME INHIBITOR)
- Charges
- 118,3280